体外膜氧合能否改善儿童急性呼吸衰竭生存?
本研究基于RESTORE试验队列,将61例接受ECMO支持的严重ARDS患儿与配对匹配的非ECMO支持患儿比较。个体匹配(60对)和倾向评分匹配(61对)均显示两组住院死亡率无差异(25% vs 25%,P>0.99;25% vs 30%,P=0.70),次要结局亦无差异。
要点
- 严重ARDS患儿中,ECMO支持与非ECMO支持的住院死亡率无显著差异。
- 个体匹配与倾向评分匹配结果一致,次要结局均无差异。
- ECMO疗效需多中心随机对照试验进一步验证。
核心结论
- 在严重ARDS患儿中,ECMO支持与否的住院死亡率和功能状态无显著差异。
研究设计与样本
- 队列研究,比较ECMO支持的严重ARDS患儿与配对匹配的非ECMO支持对照。
- 样本来自RESTORE集群随机临床试验,共2449例患儿中61例(2.5%)接受ECMO支持,879例(35.9%)非ECMO支持且符合匹配条件。
- 采用个体病例匹配和倾向评分匹配两种方法。
主要发现
- 个体匹配(60对)90天住院死亡率均为25%(15/60),P>0.99。
- 倾向评分匹配(61对)ECMO支持住院死亡率为25%(15/61),非ECMO支持为30%(18/61),P=0.70。
- 两组在任何次要结局(无住院天数、无呼吸机天数、出院时功能状态变化)上均无差异。
临床怎么用
- 对于严重ARDS患儿,ECMO支持未显示优于非ECMO支持的结局,临床决策需个体化评估。
局限性
- 非随机对照设计,可能存在未测量混杂。
- ECMO支持患儿样本量较小(61例)。
- 明确结论需严谨的多中心随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Extracorporeal membrane oxygenation (ECMO) has supported gas exchange in children with severe respiratory failure for more than 40 years, without ECMO efficacy studies. OBJECTIVES: To compare the mortality and functional status of children with severe acute respiratory failure supported with and without ECMO. METHODS: This cohort study compared ECMO-supported children to pair-matched non-ECMO-supported control subjects with severe acute respiratory distress syndrome (ARDS). Both individual case matching and propensity score matching were used. The study sample was selected from children enrolled in the cluster-randomized RESTORE (Randomized Evaluation of Sedation Titration for Respiratory Failure) clinical trial. Detailed demographic and daily physiologic data were used to match patients. The primary endpoint was in-hospital mortality. Secondary outcomes included hospital-free days, ventilator-free days, and change in functional status at hospital discharge. MEASUREMENTS AND MAIN RESULTS: Of 2,449 children in the RESTORE trial, 879 (35.9%) non-ECMO-supported patients with severe ARDS were eligible to match to 61 (2.5%) ECMO-supported children. When individual case matching was used (60 matched pairs), the in-hospital mortality rate at 90 days was 25% (15 of 60) for both the ECMO-supported and non-ECMO-supported children (P > 0.99). With propensity score matching (61 matched pairs), the ECMO-supported in-hospital mortality rate was 15 of 61 (25%), and the non-ECMO-supported hospital mortality rate was 18 of 61 (30%) (P = 0.70). There was no difference between ECMO-supported and non-ECMO-supported patients in any secondary outcomes. CONCLUSIONS: In children with severe ARDS, our results do not demonstrate that ECMO-supported children have superior outcomes compared with non-ECMO-supported children. Definitive answers will require a rigorous multisite randomized controlled trial.
引用
- Barbaro RP, Xu Y, Borasino S, et al. Does Extracorporeal Membrane Oxygenation Improve Survival in Pediatric Acute Respiratory Failure? Am J Respir Crit Care Med. 2018. PMID: 29373797. doi:10.1164/rccm.201709-1893OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。